LASTACAFT - 0023-4290-03 - (alcaftadine)

Alphabetical Index


Drug Information of LASTACAFT

Product NDC: 0023-4290
Proprietary Name: LASTACAFT
Non Proprietary Name: alcaftadine
Active Ingredient(s): 2.5    mg/mL & nbsp;   alcaftadine
Administration Route(s): OPHTHALMIC
Dosage Form(s): SOLUTION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of LASTACAFT

Product NDC: 0023-4290
Labeler Name: Allergan, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022134
Marketing Category: NDA
Start Marketing Date: 20101101

Package Information of LASTACAFT

Package NDC: 0023-4290-03
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-03) > 3 mL in 1 BOTTLE, PLASTIC

NDC Information of LASTACAFT

NDC Code 0023-4290-03
Proprietary Name LASTACAFT
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-03) > 3 mL in 1 BOTTLE, PLASTIC
Product NDC 0023-4290
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name alcaftadine
Dosage Form Name SOLUTION/ DROPS
Route Name OPHTHALMIC
Start Marketing Date 20101101
Marketing Category Name NDA
Labeler Name Allergan, Inc.
Substance Name ALCAFTADINE
Strength Number 2.5
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of LASTACAFT


General Information